Legis Daily

DEA Enforcement and Authority Act of 2021

USA117th CongressS-1594| Senate 
| Updated: 5/12/2021
Joe Manchin

Joe Manchin

Independent Senator

West Virginia

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
DEA Enforcement and Authority Act of 2021 This bill modifies enforcement authorities of the Drug Enforcement Administration (DEA). First, the bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration due to a violation of the Controlled Substances Act. Specifically, the bill eliminates the requirement that an order to show cause must notify the registrant of the opportunity to submit a corrective action plan. Second, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health or safety. This bill lowers the standard for determining imminent danger to the public health or safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-424
DEA Enforcement and Authority Act of 2019
May 12, 2021
Introduced in Senate
May 12, 2021
Read twice and referred to the Committee on the Judiciary.
  • Bill from Previous Congress

    S 116-424
    DEA Enforcement and Authority Act of 2019


  • May 12, 2021
    Introduced in Senate


  • May 12, 2021
    Read twice and referred to the Committee on the Judiciary.

Crime and Law Enforcement

Administrative remediesDepartment of JusticeDrug Enforcement Administration (DEA)Drug trafficking and controlled substancesLicensing and registrations

DEA Enforcement and Authority Act of 2021

USA117th CongressS-1594| Senate 
| Updated: 5/12/2021
DEA Enforcement and Authority Act of 2021 This bill modifies enforcement authorities of the Drug Enforcement Administration (DEA). First, the bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration due to a violation of the Controlled Substances Act. Specifically, the bill eliminates the requirement that an order to show cause must notify the registrant of the opportunity to submit a corrective action plan. Second, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health or safety. This bill lowers the standard for determining imminent danger to the public health or safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-424
DEA Enforcement and Authority Act of 2019
May 12, 2021
Introduced in Senate
May 12, 2021
Read twice and referred to the Committee on the Judiciary.
  • Bill from Previous Congress

    S 116-424
    DEA Enforcement and Authority Act of 2019


  • May 12, 2021
    Introduced in Senate


  • May 12, 2021
    Read twice and referred to the Committee on the Judiciary.
Joe Manchin

Joe Manchin

Independent Senator

West Virginia

Judiciary Committee

Crime and Law Enforcement

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative remediesDepartment of JusticeDrug Enforcement Administration (DEA)Drug trafficking and controlled substancesLicensing and registrations